A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies
Clinical trial NCT01830010 · COMPLETED
Trial details
- NCT number
- NCT01830010
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-28
- Primary completion
- 2018-08-21
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.